Cargando…

Progenitor Cell Therapy to Treat Acute Myocardial Infarction: The Promise of High-Dose Autologous CD34(+) Bone Marrow Mononuclear Cells

ST elevation myocardial infarction (STEMI) is associated with an increased risk for congestive heart failure and long-term mortality despite the widespread use of thrombolysis and catheter-based revascularization. The need for improved post-STEMI therapies has led to a surge of novel therapeutics, e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poole, Joseph C., Quyyumi, Arshed A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655659/ https://www.ncbi.nlm.nih.gov/pubmed/23737803 http://dx.doi.org/10.1155/2013/658480

Ejemplares similares

Bone marrow mononuclear cells and acute myocardial infarction
por: Arnous, Samer, et al.
Publicado: (2012)

Autologous Bone Marrow Mononuclear Cells (BMMC)-Associated Anti-Inflammatory Nanoparticles for Cardiac Repair after Myocardial Infarction
por: Uemura, Laercio, et al.
Publicado: (2022)

Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction
por: Leblond, Anne-Laure, et al.
Publicado: (2009)

The effect of rigorous study design in the research of autologous bone marrow-derived mononuclear cell transfer in patients with acute myocardial infarction
por: Jeong, Hyunsuk, et al.
Publicado: (2013)

The density of bone marrow mononuclear cells and CD34+ cells in patients with three neurologic conditions
por: Nguyen, Kien Trung, et al.
Publicado: (2023)

Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction
por: Micheu, Miruna Mihaela, et al.
Publicado: (2017)

Strengthening effects of bone marrow mononuclear cells with intensive atorvastatin in acute myocardial infarction
por: Yang, Yue-Jin, et al.
Publicado: (2020)

Infarcted myocardium-like stiffness contributes to endothelial progenitor lineage commitment of bone marrow mononuclear cells
por: Zhang, Shuning, et al.
Publicado: (2011)

Autologous Mesenchymal Stem Cells Show More Benefit on Systolic Function Compared to Bone Marrow Mononuclear Cells in a Porcine Model of Chronic Myocardial Infarction
por: van der Spoel, T. I. G., et al.
Publicado: (2015)

Clinical improvement after autologous bone marrow mononuclear cell transplantation
por: Dohmann, HF, et al.
Publicado: (2003)

Autologous Bone Marrow Mononuclear Cells Intrathecal Transplantation in Chronic Stroke
por: Sharma, Alok, et al.
Publicado: (2014)

CD34(+) Cells Represent Highly Functional Endothelial Progenitor Cells in Murine Bone Marrow
por: Yang, Junjie, et al.
Publicado: (2011)

Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up‡
por: Cao, Feng, et al.
Publicado: (2009)

The Effect of Intracoronary Infusion of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells on Remodeling of Post-Infarcted Heart in Patient with Acute Myocardial Infarction
por: Peregud-Pogorzelska, Małgorzata, et al.
Publicado: (2020)

CD34+ hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation
por: ALADAĞ, Elifcan, et al.
Publicado: (2020)

Study of Peripheral Mononuclear Cells and CD34 Levels as a Predictive Marker for Initiating Apheresis in Autologous Stem Cell Transplant
por: Pura Krishnamurthy, Kiran, et al.
Publicado: (2021)

Long-Term Outcome of Combined (Percutaneous Intramyocardial and Intracoronary) Application of Autologous Bone Marrow Mononuclear Cells Post Myocardial Infarction: The 5-Year MYSTAR Study
por: Gyöngyösi, Mariann, et al.
Publicado: (2016)

Plerixafor for autologous CD34(+) cell mobilization
por: Salman, Huda, et al.
Publicado: (2011)

Autologous bone marrow mononuclear cells as neuroprotective treatment of amyotrophic lateral sclerosis
por: Ruiz-López, Francisco José, et al.
Publicado: (2016)

Initial clinical outcomes of intracoronary infusion of autologous progenitor cells in patients with acute myocardial infarction
por: Jazi, Seyed Mohammad Hashemi, et al.
Publicado: (2012)

Highly elevated polygenic risk scores are better predictors of myocardial infarction risk early in life than later
por: Isgut, Monica, et al.
Publicado: (2021)

Flow cytometric data analysis of circulating progenitor cell stability
por: Mahar, Ernestine A., et al.
Publicado: (2016)

Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: Novel strategy for cardiac regeneration
por: Malecki, Marek, et al.
Publicado: (2013)

Identification and characterization of osteoclast-like cells and their progenitors in cultures of feline marrow mononuclear cells
Publicado: (1984)

Autologous bone marrow-derived mononuclear cell therapy in three patients with severe asthma
por: Aguiar, Fabio S., et al.
Publicado: (2020)

Immunoregulatory properties of erythroid nucleated cells induced from CD34+ progenitors from bone marrow
por: Shevchenko, Julia A., et al.
Publicado: (2023)

Mobilization and collection of CD34(+) cells for autologous transplantation of peripheral blood hematopoietic progenitor cells in children: analysis of two different granulocyte-colony stimulating factor doses
por: Eid, Kátia Aparecida de Brito, et al.
Publicado: (2015)

Relation between the frequency of CD34(+ )bone marrow derived circulating progenitor cells and the number of diseased coronary arteries in patients with myocardial ischemia and diabetes
por: Bozdag-Turan, Ilkay, et al.
Publicado: (2011)

Autologous bone marrow mononuclear cell transplantation in Duchenne muscular dystrophy – a case report
por: Sharma, Alok, et al.
Publicado: (2014)

Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Proof of Concept Study
por: Sharma, Alok, et al.
Publicado: (2013)

Efficacy of autologous bone marrow mononuclear cell transplantation in dogs with chronic spinal cord injury
por: Tamura, Katsutoshi, et al.
Publicado: (2020)

Bone Marrow Mononuclear Cell Transplantation Restores Inflammatory Balance of Cytokines after ST Segment Elevation Myocardial Infarction
por: Alestalo, Kirsi, et al.
Publicado: (2015)

Mast Cell-Activated Bone Marrow Mesenchymal Stromal Cells Regulate Proliferation and Lineage Commitment of CD34(+) Progenitor Cells
por: Allakhverdi, Zoulfia, et al.
Publicado: (2013)

Adipocytokines and CD34(+) Progenitor Cells in Alzheimer's Disease
por: Bigalke, Boris, et al.
Publicado: (2011)

Index of CD34+ Cells and Mononuclear Cells in the Bone Marrow of Spinal Cord Injury Patients of Different Age Groups: A Comparative Analysis
por: Dedeepiya, Vidyasagar Devaprasad, et al.
Publicado: (2012)

Intrathecal Administration of Autologous CD34 Positive Cells in Patients with Past Cerebral Infarction: A Safety Study
por: Wang, Liming, et al.
Publicado: (2013)

Intravitreal use of bone marrow mononuclear fraction containing CD34(+) stem cells in patients with atrophic age-related macular degeneration
por: Cotrim, Carina Costa, et al.
Publicado: (2017)

Intravitreal Use of a Bone Marrow Mononuclear Fraction (BMMF) Containing CD34+ Cells in Patients with Stargardt Type Macular Dystrophy
por: Cotrim, Carina Costa, et al.
Publicado: (2020)

Gene expression profiles associated with acute myocardial infarction and risk of cardiovascular death
por: Kim, Jinhee, et al.
Publicado: (2014)

Timing for intracoronary administration of bone marrow mononuclear cells after acute ST-elevation myocardial infarction: a pilot study
por: Huang, Rongchong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qolp1cb8jrro9l0uluj0pndph7